<?xml version="1.0" encoding="UTF-8"?>
<p>Globally, one of the main concerns is whether seasonal influenza vaccine supply is adequate to meet the needs of all countries for future pandemics [
 <xref ref-type="bibr" rid="B13">13</xref>,
 <xref ref-type="bibr" rid="B24">24</xref>,
 <xref ref-type="bibr" rid="B25">25</xref>]. A survey among 10 countries in Southeast Asia, where influenza pandemics are likely to emerge, found seasonal influenza vaccine sales in the private sector average &lt;1000 doses per 100,000 population and guidelines for vaccine use in only half of these countries [
 <xref ref-type="bibr" rid="B20">20</xref>]. In contrast, 5/15 (33%) of the African countries with influenza vaccine reported having national guidelines for influenza vaccines. Investment in influenza research to promote evidence-based influenza public health policies in Africa is essential to encouraging policy development and implementation.
</p>
